| Name | (S)-Amlodipine |
|---|---|
| Synonyms |
Norvasc
3,5-Pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester, (4S)-, benzenesulfonate (1:1) l-Amlodipine Levamlodipine Besylate Tablets LevoaMlodipine 3,5-Pyridinedicarboxylic acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester T6M DHJ B1O2Z CVO2 DR BG& EVO1 F1 2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic acid 3-ethyl 5-methyl Ester Lodien UNII:1J444QC288 3-Ethyl 5-methyl 2-{[(2-aminoethyl)oxy]methyl}-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate Levamlodipine 3,5-Pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester 3-Ethyl 5-methyl (4S)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate benzenesulfonate (1:1) Amlodipine Levoamlodipine Besylate 3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate 3-Ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate |
| Description | Levamlodipine ((S)-Amlodipine) is a powerful dihydropyridine calcium channel blocker, possessing vasodilation properties and used in the treatment of hypertension and angina[1]. |
|---|---|
| Related Catalog | |
| Target |
Calcium channel[1]. |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 527.2±50.0 °C at 760 mmHg |
| Melting Point | 102-104°C |
| Molecular Formula | C20H25ClN2O5 |
| Molecular Weight | 567.051 |
| Flash Point | 272.6±30.1 °C |
| Exact Mass | 566.148987 |
| PSA | 99.88000 |
| LogP | 4.16 |
| Vapour Pressure | 0.0±1.4 mmHg at 25°C |
| Index of Refraction | 1.546 |
| Storage condition | -20°C Freezer |
| Hazard Codes | Xi |
|---|
|
~%
103129-82-4 |
| Literature: WO2008/51056 A1, ; Page/Page column 5; 7; 8 ; |
|
~%
103129-82-4 |
| Literature: Journal of Medicinal Chemistry, , vol. 29, # 9 p. 1696 - 1702 |
|
~64%
103129-82-4 |
| Literature: Goldmann; Stoltefuss; Born Journal of Medicinal Chemistry, 1992 , vol. 35, # 18 p. 3341 - 3344 |
|
~%
103129-82-4 |
| Literature: Journal of Medicinal Chemistry, , vol. 29, # 9 p. 1696 - 1702 |
|
~%
103129-82-4 |
| Literature: Journal of Medicinal Chemistry, , vol. 29, # 9 p. 1696 - 1702 |
|
~%
103129-82-4 |
| Literature: Journal of Medicinal Chemistry, , vol. 29, # 9 p. 1696 - 1702 |
|
~%
103129-82-4 |
| Literature: Journal of Medicinal Chemistry, , vol. 29, # 9 p. 1696 - 1702 |
|
~%
103129-82-4 |
| Literature: WO2010/148191 A2, ; Page/Page column 45-49; 59 ; |
|
~%
103129-82-4 |
| Literature: Journal of Medicinal Chemistry, , vol. 35, # 18 p. 3341 - 3344 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |